Given the uncertainties associated with valuation of biotech enterprises, valuers can put stronger effort in benchmarking. A solid pool of comparable listed companies and comparable transaction will be highly useful to support valuation assumptions at different clinical trial phase.
The staff of Hong Kong Institute of CPAs and the staff of Accounting Standards Board of Japan (ASBJ) published a research paper (RP), Goodwill: Improvements to Subsequent Accounting and an Update of the Quantitative Study in March 2020. We would like to highlight some interesting findings from the paper: A steady increase in
We have developed strong database, technology and team for efficient turnaround. No matter which auditors you use, we are experienced to handle the expected and unexpected issues that may arise.